I have an amendment at the desk. The Acting CHAIR. The Clerk will designate the amendment. The text of the amendment is as follows: Page 24, strike line 3 and all that follows through page 25, line 12, and insert the following: (n) Effective Date.-- (1) In general.--The amendments made by this section-- (A) shall take effect 90 days after the date on which the President issues an Executive order containing the President's finding that major patenting authorities have adopted a grace period having substantially the same effect as that contained under the amendments made by this section; and (B) shall apply to all applications for patent that are filed on or after the effective date under subparagraph (A). (2) Definitions.--In this subsection: (A) Major patenting authorities.--The term ``major patenting authorities'' means at least the patenting authorities in Europe and Japan. (B) Grace period.--The term ``grace period'' means the 1- year period ending on the effective filing date of a claimed invention, during which disclosures of the subject matter by the inventor or a joint inventor, or by others who obtained the subject matter disclosed directly or indirectly from the inventor or a joint inventor, do not qualify as prior art to the claimed invention.…
Share
More from John Conyers
Although H.R. 469 has many flaws, I am particularly concerned that the bill's broad and ill-defined requirements would effectively delay and possibly deter civil enforcement agencies from providing general relief in discrimination cases…
Unfortunately, the current administration in swift fashion abandoned America's bipartisan leadership in this arena.
My amendment would exempt from H.R. 732 settlement agreements that direct funds to remediate the indirect but catastrophic effects of unlawful conduct resulting in lead contamination in public drinking water. Lead contamination in public…
We should of course remain vigilant about pay-for-delay schemes, whereby branded drug manufacturers pay generic manufacturers to delay the entry of a version of branded drugs as the patent on the branded drug expires.





